SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-053801
Filing Date
2023-02-28
Accepted
2023-02-28 16:02:59
Documents
7
Effectiveness Date
2023-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 d419347ds8.htm S-8 58582
2 EX-5.1 d419347dex51.htm EX-5.1 13867
3 EX-23.1 d419347dex231.htm EX-23.1 1499
4 EX-99.2 d419347dex992.htm EX-99.2 70826
5 EX-99.3 d419347dex993.htm EX-99.3 73201
6 EX-FILING FEES d419347dexfilingfees.htm EX-FILING FEES 18876
7 GRAPHIC g419347g0228021147648.jpg GRAPHIC 2512
  Complete submission text file 0001193125-23-053801.txt   241440
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270088 | Film No.: 23685051
SIC: 2834 Pharmaceutical Preparations